Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Research · April 29, 2023

Efficacy of the Adjuvanted Recombinant Zoster Vaccine in Reducing the Duration of Zoster-Associated Pain



Additional Info

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials
Pain 2023 Apr 01;164(4)741-748, JH Kim, R Johnson, M Kovac, AL Cunningham, M Amakrane, KM Sullivan, AF Dagnew, D Curran, A Schuind

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading